<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04673812</url>
  </required_header>
  <id_info>
    <org_study_id>MS/19.09.830</org_study_id>
    <nct_id>NCT04673812</nct_id>
  </id_info>
  <brief_title>Influence Of Low Dose Intrathecal Naloxone On Bupivacaine - Fentanyl Spinal Anaesthesia For Lower Limb Orthopedic Surgery In Elderly Patients</brief_title>
  <official_title>Influence Of Low Dose Intrathecal Naloxone On Bupivacaine - Fentanyl Spinal Anaesthesia For Lower Limb Orthopedic Surgery In Elderly Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fentanyl is a safer alternative than morphine in the management of postoperative pain in&#xD;
      elderly. However, pruritus, nausea and vomiting are unwanted side effects of intrathecal&#xD;
      fentanyl administration, that can decrease patient satisfaction with anaesthesia, delay post&#xD;
      anaesthesia care unit ( PACU ) discharge, and increase costs.&#xD;
&#xD;
      The incidence of pruritus with neuraxial fentanyl is high. The incidence of pruritus in&#xD;
      non-obstetric surgery patients after intrathecal fentanyl ranges from 53% to 79%.&#xD;
&#xD;
      Naloxone hydrochloride is a pure opioid competitive antagonist. Small doses of naloxone may&#xD;
      reduce Fentanyl-associated adverse effects, such as pruritus, nausea and vomiting without&#xD;
      affecting analgesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the effect of adding low dose intathecal naloxone to&#xD;
      bupivacaine - fentanyl spinal anesthesia in elderly patients scheduled for unilateral lower&#xD;
      limb orthopedic surgeries on opioid induced side effects namely pruritus, postoperative&#xD;
      analgesia and the incidence of postoperative cognitive dysfunction (POCD) in elderly.&#xD;
&#xD;
      A four category verbal rating scale VRS-4 ( 0 to 3 scale ) will be used for assessment of&#xD;
      intrathecal fentanyl induced side effects including pruritus, nausea, vomiting and shivering.&#xD;
&#xD;
      Mini Mental State Examination ( MMSE ) test will be applied to all patients pre- and post-&#xD;
      operative to assess the incidence and the degree of POCD.&#xD;
&#xD;
      An 11 points Verbal Numerical Rating Scale VNRS for pain assessment will be also applied to&#xD;
      all patients postoperatively to assess the effect on postoperative analgesia.&#xD;
&#xD;
        -  Cannulation: Peripheral cannulae ( size 20 gauge or 18 gauge ) will be inserted to all&#xD;
           patients . Ringer's acetate warmed up to 37°C will be infused slowly at rate of 7ml/kg,&#xD;
           30 min before induction of spinal anaesthesia. A single intravenous ( I.V. ) dose of&#xD;
           prophylactic antibiotic after a negative sensitivity test will be given to all patients&#xD;
           15-30 min. before operation.&#xD;
&#xD;
        -  Induction: Patient will receive spinal anaesthesia with 12.5 mg hyperbaric Bupivacaine&#xD;
           0.5% ( 2.5 mL ) plus 25 µg Fentanyl ( 0.5 mL ) and 20 µg Naloxone ( prepared in 0.5 mL&#xD;
           normal saline ) added in the same syringe in a total volume of 3.5 mL..&#xD;
&#xD;
        -  Spinal anaesthesia will be conducted while the patients are in the sitting position and&#xD;
           under complete aseptic conditions; a lumber puncture at L3-4 or L4-5 interspaces will be&#xD;
           performed with a 25- gauge Quincke spinal needle after infiltrating the skin with 2 ml&#xD;
           of lidocaine 2%. After a successful dural puncture and ensuring free flow of&#xD;
           cerebrospinal fluid, injectates will be injected slowly over 20 seconds without&#xD;
           barbotage or aspiration according to group of the patient. Immediately, patients will be&#xD;
           turned into the supine position. Oxygen 2-3 L/min will be applied to all patients via&#xD;
           nasal prongs.&#xD;
&#xD;
      Evolution and regression of sensory and motor block will be evaluated. Sensation will be&#xD;
      assessed by pinprick in the mid-clavicular line as follows; Grade 0: Sharp pain felt, Grade&#xD;
      I: Analgesia, dull sensation felt, Grade II: Anesthesia, no sensation felt. Motor blockade&#xD;
      will be assessed according to Modified Bromage Scale.&#xD;
&#xD;
      Hemodynamics ( mean arterial blood pressure MAP, heart rate HR and oxygen saturation SpO2 )&#xD;
      will be also recorded at predetermined accurate times.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 10, 2020</start_date>
  <completion_date type="Actual">March 10, 2021</completion_date>
  <primary_completion_date type="Actual">March 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of fentanyl - induced pruritus</measure>
    <time_frame>4 hours postoperative</time_frame>
    <description>A four category verbal rating scale VRS-4 ( 0 to 3 scale ) which will be will be explained to all patients, where ( 0 = no symptoms, 1 = mild symptoms, 2 = moderate symptoms, 3 = severe symptoms ) with the basal preoperative value is being recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The time for first postoperative analgesic requirements</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function using Mini Mental State Examination (MMSE) scoring</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative nausea and vomiting</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Anesthesia, Spinal</condition>
  <condition>Elderly</condition>
  <arm_group>
    <arm_group_label>Bupivacaine-Fentanyl Spinal Anaesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine-Fentanyl-Naloxone Spinal Anaesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine-fentanyl</intervention_name>
    <description>Bupivacaine-Fentanyl (BF) group (46 patients): will receive spinal anaesthesia with 12.5 mg hyperbaric Bupivacaine 0.5% (2.5 mL) plus 25 µg Fentanyl (0.5 mL) and (0.5 mL) normal saline added in the same syringe in a total volume of 3.5 mL.&#xD;
Bupivacaine-Fentanyl-Naloxone (BFN) group (46 patients): will receive spinal anaesthesia with 12.5 mg hyperbaric Bupivacaine 0.5% (2.5 mL) plus 25 µg Fentanyl (0.5 mL) and 20 µg Naloxone (prepared in 0.5 mL normal saline) added in the same syringe in a total volume of 3.5 mL.</description>
    <arm_group_label>Bupivacaine-Fentanyl Spinal Anaesthesia</arm_group_label>
    <arm_group_label>Bupivacaine-Fentanyl-Naloxone Spinal Anaesthesia</arm_group_label>
    <other_name>Naloxone hydrochloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 60y of either gender.&#xD;
&#xD;
          -  ASA physical status III or below.&#xD;
&#xD;
          -  Patients scheduled for elective unilateral lower limb orthopedic surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Morbid obese patients.&#xD;
&#xD;
          -  Severe or uncompensated cardiovascular, renal, hepatic or endocrinal diseases.&#xD;
&#xD;
          -  Allergy to one of the agents used.&#xD;
&#xD;
          -  Severely altered consciousness level.&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Increased intracranial pressure&#xD;
&#xD;
          -  Neuromuscular diseases&#xD;
&#xD;
          -  Severe spinal deformity&#xD;
&#xD;
          -  Patients on opioid analgesics or opioid abuse&#xD;
&#xD;
          -  Multi traumatized patients&#xD;
&#xD;
          -  Patients with preoperative Mini Mental State Examination ( MMSE ) scoring &lt; 24&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Y. Makharita, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasralainy</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 13, 2020</study_first_submitted>
  <study_first_submitted_qc>December 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>March 14, 2021</last_update_submitted>
  <last_update_submitted_qc>March 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Khaled Abdelfattah Abdallah Sarhan</investigator_full_name>
    <investigator_title>lecturer of anesthesia,SICU and pain management</investigator_title>
  </responsible_party>
  <keyword>spinal anesthesia</keyword>
  <keyword>elderly</keyword>
  <keyword>naloxone</keyword>
  <keyword>pruritus</keyword>
  <keyword>post operative cognitive dysfunction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Naloxone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

